availability of compounded semaglutide (GLP-1) Troubling Findings in Study of

Even people who achieve the treatment goals with the new obesity pharmacotherapies might decide to undergo bariatric surgery to support long-term weight maintenance because either they experience weight regain on the medication or they do not have long-term access to obesity pharmacotherapy, or they prefer not to take obesity pharmacotherapy lifelong

To be eligible , you must have private or commercial insurance that covers Ozempic and be a citizen or resident of the United States

They called for more research into the possible carcinogenic qualities of GLP-1 drugs

The new trial tells us that the mechanism of heart benefit is not only dependent on weight loss since a similar magnitude of symptomatic relief was seen in the 2 trials

It tanks your metabolism and sets you up for rapid weight regain once you come off the medication

Our experience shows that labeling the vial with the date of reconstitution and the final concentration (e.g., "Recon 10/26 5mg/mL") is a foolproof way to prevent this